Raju Khatri, Ph.D. - Publications

Affiliations: 
2013 Toxicology University of Maryland School of Medicine, Baltimore, MD, United States 
Area:
Oncology, Cell Biology, Molecular Biology

6 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Portney BA, Arad M, Gupta A, Brown RA, Khatri R, Lin PN, Hebert AM, Angster KH, Silipino LE, Meltzer WA, Taylor RJ, Zalzman M. ZSCAN4 facilitates chromatin remodeling and promotes the cancer stem cell phenotype. Oncogene. PMID 32507861 DOI: 10.1038/S41388-020-1333-1  0.38
2018 Khatri R, Shah P, Guha R, Rassool FV, Tomkinson AE, Brodie A, Jaiswal AK. Retraction: Aromatase Inhibitor-mediated Downregulation of INrf2 (Keap1) Leads to Increased Nrf2 and Resistance in Breast Cancer. Molecular Cancer Therapeutics. 17: 2491. PMID 30389813 DOI: 10.1158/1535-7163.MCT-17-0310  0.496
2018 Portney BA, Khatri R, Meltzer WA, Mariano JM, Zalzman M. ZSCAN4 is negatively regulated by the ubiquitin-proteasome system and the E3 ubiquitin ligase RNF20. Biochemical and Biophysical Research Communications. PMID 29477841 DOI: 10.1016/J.Bbrc.2018.02.155  0.383
2015 Khatri R, Shah P, Guha R, Rassool FV, Tomkinson AE, Brodie A, Jaiswal AK. Aromatase Inhibitor-Mediated Downregulation of INrf2 (Keap1) Leads to Increased Nrf2 and Resistance in Breast Cancer. Molecular Cancer Therapeutics. 14: 1728-37. PMID 25976679 DOI: 10.1158/1535-7163.Mct-14-0672  0.549
2014 Niture SK, Khatri R, Jaiswal AK. Regulation of Nrf2-an update. Free Radical Biology & Medicine. 66: 36-44. PMID 23434765 DOI: 10.1016/J.Freeradbiomed.2013.02.008  0.498
2010 Khatri R, Niture SK, Jaiswal AK. Abstract 4131: Activation of PKC-delta inhibits apoptosis leading to mitomycin C resistance Cancer Research. 70: 4131-4131. DOI: 10.1158/1538-7445.Am10-4131  0.536
Show low-probability matches.